Related Experiment Videos
Diagnosis and successful treatment of fusariosis in the compromised host
W G Merz1, J E Karp, M Hoagland
1Department of Pathology, Johns Hopkins Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Abstract:
We present six cases of fusariosis caused by Fusarium solani that were diagnosed over a three-year period in 166 adult patients undergoing chemotherapy for acute leukemia. Necrotic skin lesions were evident in four patients, fungemia in three, and a deep cellulitis around a great toe nail at the time of a febrile illness in two. The mean minimal inhibitory concentration (MIC) of amphotericin B was 3.3 micrograms/mL and of miconazole, 5.3 micrograms/mL; all isolates were resistant to 5-fluorocytosine. All patients received amphotericin B (1.0-1.5 mg/kg per d) plus 5-fluorocytosine. In contrast to results found in the literature, five patients had resolution of their infections, and the one patient who died had necropsy evidence of disseminated fusariosis. Review of our cases and of the literature did not reveal a definitive source for the organism or its portal of entry. Fusarium spp. must be recognized as opportunistic pathogens that cause a potentially fatal infection in compromised patients.
Insights
Fusarium solani infections are a serious risk for acute leukemia patients on chemotherapy. Despite resistance to some antifungals, most patients in this study successfully recovered with amphotericin B treatment.
Area of Science:
- Mycology
- Infectious Diseases
- Hematology
Background:
- Fusariosis, a fungal infection caused by Fusarium species, poses a significant threat to immunocompromised individuals.
- Patients undergoing chemotherapy for acute leukemia are particularly vulnerable to opportunistic infections.